scholarly journals The maraviroc expanded access program — safety and efficacy data from an open-label study

2015 ◽  
Vol 16 (1) ◽  
pp. 10-21 ◽  
Author(s):  
Adriano Lazzarin ◽  
Jacques Reynes ◽  
Jean-Michel Molina ◽  
Srinivas Valluri ◽  
Geoffrey Mukwaya ◽  
...  
Keyword(s):  
Open Label ◽  
Efficacy Data ◽  
Open Label Study ◽  
Label Study ◽  
Safety And Efficacy ◽  
Expanded Access ◽  
Expanded Access Program ◽  
Access Program ◽  
Program Safety

Single-arm, open label study of pemetrexed plus cisplatin in chemotherapy naïve patients with malignant pleural mesothelioma: Outcomes of an expanded access program

Lung Cancer ◽  
2007 ◽  
Vol 55 (2) ◽  
pp. 187-194 ◽  
Author(s):  
Coleman K. Obasaju ◽  
Zhishen Ye ◽  
Antoinette J. Wozniak ◽  
Chandra P. Belani ◽  
Mary-Louise Keohan ◽  
...  
Keyword(s):  
Malignant Pleural Mesothelioma ◽  
Pleural Mesothelioma ◽  
Open Label ◽  
Open Label Study ◽  
Label Study ◽  
Expanded Access ◽  
Expanded Access Program ◽  
Access Program

Open-Label Study of Pemetrexed Alone or in Combination with Cisplatin for the Treatment of Patients with Peritoneal Mesothelioma: Outcomes of an Expanded Access Program

2005 ◽  
Vol 7 (1) ◽  
pp. 40-46 ◽  
Author(s):  
Pasi A. Jänne ◽  
Antoinette J. Wozniak ◽  
Chandra P. Belani ◽  
Mary-Louise Keohan ◽  
Helen J. Ross ◽  
...  
Keyword(s):  
Peritoneal Mesothelioma ◽  
Open Label ◽  
Open Label Study ◽  
Label Study ◽  
Expanded Access ◽  
Expanded Access Program ◽  
Access Program

scholarly journals Safety and Efficacy of Oral Human Parathyroid Hormone (1‐34) in Hypoparathyroidism: An Open‐Label Study

2021 ◽  
Author(s):  
Sofia Ish‐Shalom ◽  
Yoseph Caraco ◽  
Nariman Saba Khazen ◽  
Michal Gershinsky ◽  
Auryan Szalat ◽  
...  
Keyword(s):  
Parathyroid Hormone ◽  
Human Parathyroid Hormone ◽  
Open Label ◽  
Open Label Study ◽  
Label Study ◽  
Safety And Efficacy
Sign in / Sign up

Export Citation Format

Share Document